Discussions

Deals like the recent preferred provider agreement to supply specialty drugs are not only anti-competitive for business, they also restrict patients’ choice of where to obtain healthcare and ultimately, reduce the incentives for pharmacies to innovate.

The survey indicates that 57% of English respondents frequently encountered false or misleading health information.

We all know that lightbulbs work when negative electrons move to the positive terminal and in this case, a flow of ideas and actions improve patient outcomes.

Have you noticed an uptick along with the proliferation of pharmacies advertising more clinical services?

Provinces and territories determine not only the drugs to be reimbursed in their jurisdiction but also the conditions under which people can access them.

Do these drugs point toward a root cause of metabolic disease? What inspired their development in the first place?

Can’t find the time to step away from the treadmill and re-set your priorities? A mini-retreat might be just the thing. Here’s what to expect if you decide to try one.

See what your colleagues say. Take our weekly doctor poll.